The CRO and software provider for small molecule discovery, Cresset, is collaborating with Elixir to create a new platform for efficient drug discovery.
Glaukos Pharmaceutical, an ophthalmic medical technology and pharmaceutical company, and D. Western Therapeutics Institute (DWTI), a Japanese biotechnology company, have announced an agreement.
BioFocus has sealed two compound management deals with the National Cancer Institute and eMolecules, while extending its relationship with Chiesi Farmaceutici for $3.5m (€2.5m).
An escalation in drug discovery activities in the Asia Pacific
region is likely to cause significant growth there for technologies
used in high-throughput screening, according to a new report.